No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 14 of the 39 quarters in the window, leaving 25 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 139.4x · 10Y median 1.3x · 58th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2024-04-02. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2025-05-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2025-05-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2025-08-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2024-04-02. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2025-05-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T19:18:51.066Z. Latest historical point 2025-05-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for USA Rare Earth Inc (USAR) stock was $13.83 as of Oct 6, 2026, 3:15 PM EDT, up 1.32% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -47.3% · 3-year avg +10.1%/yr
USA Rare Earth Inc. specializes in the production of magnets.
Industrial Materials · Stillwater, OK
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
-0.10
Revenue Est.
$13.09M
Last Quarter Results
EPS
$-0.15
vs Estimate
$-0.13
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1USAR | $1.83B | $13.83 | +1.32% | -47.26% | N/A | N/A | N/A |
| 2HYMC | $1.77B | $19.02 | +1.17% | +199.70% | +4.21% | N/A | vs USAR |
| 3MTX | $2.05B | $65.95 | -0.38% | +6.24% | -1.25% | -0.18% | vs USAR |
| 4TMC | $1.61B | $3.71 | -1.59% | -48.96% | -3.31% | N/A | vs USAR |
| 5IOSP | $2.43B | $98.49 | +0.86% | +26.83% | +4.20% | +6.30% | vs USAR |
| 6ELE | $1.18B | $18.37 | +1.58% | N/A | N/A | N/A | vs USAR |
forward FY estimate
N/A
$5.82M
vs Estimate
$8.04M
Consensus Rating
Based on 9 analysts
Average Price Target
$35.56
+157.1% upside
Low
$21.00
Current
$13.83
High
$45.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.20 | $-0.10 | $-0.02 | 4 |
| Quarter ending Dec 2026 | $-0.11 | $-0.10 | $-0.09 | 2 |
| Quarter ending Mar 2027 | $-0.09 | $-0.07 | $-0.04 | 1 |
| Quarter ending Jun 2027 | $-0.06 | $-0.04 | $-0.03 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.68 | $-0.54 | $-0.40 | 3 |
| FY 2027 | $-0.12 | $-0.07 | $-0.03 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $9.37M | $13.09M | $21.87M | 6 |
| Quarter ending Dec 2026 | $37.74M | $42.61M | $47.48M | 4 |
| Quarter ending Mar 2027 | $81.52M | $107.98M | $136.98M | 2 |
| Quarter ending Jun 2027 | $104.13M | $137.92M | $174.96M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $62.01M | $68.14M | $74.28M | 5 |
| FY 2027 | $504.38M | $635.76M | $767.14M | 4 |
